Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.70 CNY
320.41 M CNY
3.76 B CNY
273.67 M
About ZHUZHOU QIANJIN PHARMACEUTICAL
Sector
CEO
Zhi Yong Chen
Headquarters
Zhuzhou
Website
Founded
1966
ISIN
CNE000001GX3
FIGI
BBG000BFFF94
Zhuzhou Qianjin Pharmaceutical Co., Ltd. engages in the manufacture, research, production and sales of Chinese patent medicines, chemical medicines and feminine hygiene products, as well as wholesale and retail business of pharmaceutical products. Its business activities include Chinese medicine, chemical medicine, and health supplies businesses. It produces medicines in the form of tablets, granules, and hard capsules. Its products are used for treatment of gynecological and obstetric, pediatric, circulatory, endocrine, digestive system, nervous system, and cardiovascular diseases. The company was founded in 1966 and is headquartered in Zhuzhou, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600479 is 12.88 CNY — it has increased by 7.24% in the past 24 hours. Watch ZHUZHOU QIANJIN PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange ZHUZHOU QIANJIN PHARMACEUTICAL stocks are traded under the ticker 600479.
600479 stock has risen by 18.71% compared to the previous week, the month change is a 14.18% rise, over the last year ZHUZHOU QIANJIN PHARMACEUTICAL has showed a 10.46% increase.
600479 reached its all-time high on Jun 15, 2015 with the price of 26.43 CNY, and its all-time low was 2.05 CNY and was reached on Jul 21, 2005. View more price dynamics on 600479 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600479 stock is 9.98% volatile and has beta coefficient of 0.92. Track ZHUZHOU QIANJIN PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is ZHUZHOU QIANJIN PHARMACEUTICAL there?
Today ZHUZHOU QIANJIN PHARMACEUTICAL has the market capitalization of 5.39 B, it has increased by 11.93% over the last week.
Yes, you can track ZHUZHOU QIANJIN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
600479 net income for the last quarter is 50.35 M CNY, while the quarter before that showed 71.52 M CNY of net income which accounts for −29.60% change. Track more ZHUZHOU QIANJIN PHARMACEUTICAL financial stats to get the full picture.
Yes, 600479 dividends are paid annually. The last dividend per share was 0.35 CNY. As of today, Dividend Yield (TTM)% is 2.72%. Tracking ZHUZHOU QIANJIN PHARMACEUTICAL dividends might help you take more informed decisions.
ZHUZHOU QIANJIN PHARMACEUTICAL dividend yield was 3.25% in 2023, and payout ratio reached 45.72%. The year before the numbers were 3.65% and 48.42% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 5.33 K employees. See our rating of the largest employees — is ZHUZHOU QIANJIN PHARMACEUTICAL on this list?
Like other stocks, 600479 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHUZHOU QIANJIN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHUZHOU QIANJIN PHARMACEUTICAL technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHUZHOU QIANJIN PHARMACEUTICAL stock shows the strong buy signal. See more of ZHUZHOU QIANJIN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.